Friday, June 20th, 2008 Posted in skin health | No Comments »
Forest Laboratories, Inc. (NYSE: FRX) announced positive results from two globally conducted, multi-center Phase III studies of ceftaroline, a broad-spectrum cephalosporin with activity against gram-positive bacteria, such as MRSA and ... Read more..Friday, June 20th, 2008 Posted in skin health | No Comments »
Over the past few decades, the incidence of melanoma, the deadliest from of skin cancer, has increased. Melanoma has become the most common cancer in women between the ages of ... Read more..Friday, June 20th, 2008 Posted in skin health | No Comments »
Centocor, Inc. announced that the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) of the U.S. Food and Drug Administration (FDA) has unanimously recommended the approval of ustekinumab, a new subcutaneous, ... Read more..